Detail (Long)
Booster dose 95.6% relative vaccine efficacy compared w/ no booster dose, per <a href=https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-phase-3-trial-data-showing><b><u>preliminary analysis</u></b></a>